Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Four individuals' experiences during and following a psilocybin truffle retreat in the Netherlands

Anna Lutkajtis

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (54)

  1. Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin. 2020-11-01 · Expand citations
  2. Psilocybin occasioned mystical-type experiences. 2020-09-01 · Expand citations
  3. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. 2020-04-01 · Expand citations
  4. Emotions and brain function are altered up to one month after a single high dose of psilocybin. 2020-02-10 · Expand citations
  5. Replication and extension of a model predicting response to psilocybin. 2019-11-01 · Expand citations
  6. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. 2019-07-01 · Expand citations
  7. Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being. 2019-01-01 · Expand citations
  8. Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. 2019-01-01 · Expand citations
  9. Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression. 2018-07-01 · Expand citations
  10. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. 2018-07-01 · Expand citations
  11. Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder. 2018-01-01 · Expand citations
  12. Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy. 2018-01-01 · Expand citations
  13. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. 2018-01-01 · Expand citations
  14. The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions. 2018-01-01 · Expand citations
  15. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
  16. Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Distress 2017-06-14 · Expand citations
  17. Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis 2017-04-28 · Expand citations
  18. Long-term follow-up of psilocybin-facilitated smoking cessation. 2017-01-01 · Expand citations
  19. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. 2017-01-01 · Expand citations
  20. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  21. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  22. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. 2016-12-01 · Expand citations
  23. A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects 2016-05-24 · Expand citations
  24. Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice 2015-03-27 · Expand citations
  25. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  26. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. 2014-11-01 · Expand citations
  27. A qualitative report on the subjective experience of intravenous psilocybin administered in an FMRI environment. 2014-01-01 · Expand citations
  28. Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. 2014-01-01 · Expand citations
  29. Effects of Psilocybe argentipes on marble-burying behavior in mice. 2009-08-01 · Expand citations
  30. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  31. Extraction and analysis of indole derivatives from fungal biomass. 1994-01-01 · Expand citations
  32. OpenAlex W2044788246
  33. OpenAlex W2117834601
  34. OpenAlex W2325207359
  35. OpenAlex W2439685582
  36. OpenAlex W2537027964
  37. OpenAlex W2571392308
  38. OpenAlex W2584176612
  39. OpenAlex W2744933359
  40. OpenAlex W2753654430
  41. OpenAlex W2790381919
  42. OpenAlex W2900604419
  43. OpenAlex W3018943978
  44. OpenAlex W3026821888
  45. OpenAlex W3046847196
  46. OpenAlex W3049156731
  47. OpenAlex W3108285700
  48. OpenAlex W621823012
  49. OpenAlex W6677819859
  50. OpenAlex W6718383060
  51. OpenAlex W6748483571
  52. OpenAlex W6748796104
  53. OpenAlex W6749500537
  54. OpenAlex W6749774858

Cited by — these papers cite this paper (4)

  1. Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development 2026-07-03 · Expand citations
  2. Memory, trauma, and self: Remembering and recovering from sexual abuse in psychedelic-assisted therapy 2024-10-09 · Expand citations
  3. The potential of psilocybin use to enhance well-being in healthy individuals - A scoping review 2023-11-29 · Expand citations
  4. Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands 2023-01-16 · Expand citations